Alzheimer's Disease

FILE - In this Aug. 14, 2018 file photo, a doctor looks at a PET brain scan at the Banner Alzheimers Institute in Phoenix. Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because of rare gene flaws. The results announced Monday, Feb. 10, 2020, are another disappointment for the approach that scientists have focused on for many years -- trying to remove a harmful protein that builds up in the brains of people with the disease. (AP Photo/Matt York, File)
February 10, 2020 - 5:04 am
Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because they inherited rare gene flaws. The results announced Monday are another disappointment for the approach that scientists...
Read More
In this Nov. 22, 2019, photo, Charles Flagg, who is stricken with Alzheimer's disease, receives the contents of an intravenous bag while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
December 05, 2019 - 9:16 am
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday, disclosing more results that may help explain why one study of the experimental medicine succeeded and another failed. Excitement and skepticism have...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
December 04, 2019 - 5:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
November 12, 2019 - 2:40 pm
SAN FRANCISCO (AP) — Billionaire philanthropists Joan and Sandy Weill announced Tuesday they are donating $106 million to launch a research initiative at three West Coast universities aimed at finding treatments for brain disorders like epilepsy and Alzheimer's disease. The donation to the...
Read More
FILE - In this Thursday, Sept. 27, 2018 file photo, an elderly couple walks past the Berlaymont building, the European Commission headquarters, in Brussels. Research released on Sunday, July 14, 2019 suggests that a healthy lifestyle can cut the risk of developing Alzheimer's even if you've inherited genes that raise your risk for the mind-destroying disease. (AP Photo/Francisco Seco, File)
July 14, 2019 - 10:28 am
LOS ANGELES (AP) — A healthy lifestyle can cut your risk of developing Alzheimer's or other forms of dementia even if you have genes that raise your risk for these mind-destroying diseases, a large study has found. People with high genetic risk and poor health habits were about three times more...
Read More
Democratic presidential candidate Sen. Amy Klobuchar speaks to reporters during the West Des Moines Democrats' annual picnic, Wednesday, July 3, 2019, in West Des Moines, Iowa. (AP Photo/Charlie Neibergall)
July 12, 2019 - 3:00 am
WASHINGTON (AP) — Democratic presidential candidate Amy Klobuchar (KLOH'-buh-shar) has a new plan to help seniors that includes more support for people with Alzheimer's disease and their caregivers. It's an issue that's personal for the Minnesota senator, whose 91-year-old father is in a memory...
Read More
FILE - In a May 19, 2015 file photo, R. Scott Turner, Professor of Neurology and Director of the Memory Disorder Center at Georgetown University Hospital, points to PET scan results that are part of a study on Allheimer's disease at Georgetown University Hospital, in Washington. An Alzheimer’s Association survey being released Tuesday, March 5, 2019 found about half of seniors say they’ve ever discussed thinking or memory with a health provider, and less than a third report ever getting formally assessed for cognitive problems. (AP Photo/Evan Vucci, File)
March 04, 2019 - 9:05 pm
WASHINGTON (AP) — Few seniors get their thinking and memory abilities regularly tested during check-ups, according to a new report from the Alzheimer's Association that raises questions about how best to find out if a problem is brewing. Medicare pays for an annual "wellness visit" that is supposed...
Read More
Mary Radnofsky, diagnosed with a rare form of leukoencephalopathy and in the early stages of dementia, holds her service dog Benjy at her home, on Friday, Jan. 18, 2019, in Alexandria, Va. Faced with an aging American workforce, U.S. companies are increasingly navigating delicate conversations with employees suffering from cognitive declines or dementia diagnoses, experts say. (AP Photo/Kevin Wolf)
January 28, 2019 - 12:02 am
CHICAGO (AP) — Faced with an aging American workforce, companies are increasingly navigating delicate conversations with employees grappling with cognitive declines, experts say. Workers experiencing early stages of dementia may struggle with tasks they had completed without difficulty...
Read More
This Sept. 18, 2018 photo released by Opera Philadelphia, Mezzo-soprano Marietta Simpson, left, and Frederica von Stade in the new opera "Sky on Swings" premiering as part of Opera Philadelphia's O18 Festival. (Dominic M. Mercier/Opera Philadelphia via AP)
September 21, 2018 - 12:51 pm
PHILADELPHIA (AP) — "Sky on Swings," a 78-minute chamber work about two women declining from Alzheimer's disease, was given its world premiere by Opera Philadelphia for the first night of its season-opening O18 festival. Frederica von Stade, a celebrated 73-year-old mezzo-soprano, teamed with 59-...
Read More